Intestinal lipid and lipoprotein metabolism in relation with insulin-resistant and diabetic states in humans.

肠道脂质和脂蛋白代谢与人类胰岛素抵抗和糖尿病状态的关系。

• 批准号: 226200
• 负责人: Veilleux Alain
• 金额: $ 9.83万
• 依托单位: Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2011
• 资助国家: 加拿大
• 起止时间: 2011-02-01 至 2014-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=226200&lang=en
• 关键词: Apolipoprotein; Cholesterol; Insulin Resistance; Intestine; Lipid; Lipoproteins; Organ Culture

Incidence of type 2 diabetes shows a rapid and continuous rise in industrial societies such as Canada. Insulin resistance is the central feature of this pathology, but is also commonly associated with dyslipidemia. Exaggerated hepatic lipid production and

2型糖尿病的发病率在加拿大等工业社会中迅速持续上升。胰岛素抵抗是这种病理学的中心特征，但也通常与血脂异常相关。肝脏脂质生成增加，